Hexavalent chromium inhibits myogenic differentiation and induces myotube atrophy
Authors:
- 22 September 2023
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 477, 116693
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (P30 ES000260, R01 CA217923, R21 ES034811, T32 ES007324)
This publication has 51 references indexed in Scilit:
- Mechanistic Insights from the NTP Studies of ChromiumToxicologic Pathology, 2013
- Turning on Myogenin in Muscle: A Paradigm for Understanding Mechanisms of Tissue-Specific Gene ExpressionComparative and Functional Genomics, 2012
- Sodium arsenite represses the expression of myogenin in C2C12 mouse myoblast cells through histone modifications and altered expression of Ezh2, Glp, and Igf-1Toxicology and Applied Pharmacology, 2012
- Creatine-Kinase- and Exercise-Related Muscle Damage Implications for Muscle Performance and RecoveryJournal of Nutrition and Metabolism, 2012
- Differentiation and fiber type-specific activity of a muscle creatine kinase intronic enhancerSkeletal Muscle, 2011
- Sodium arsenite delays the differentiation of C2C12 mouse myoblast cells and alters methylation patterns on the transcription factor myogeninToxicology and Applied Pharmacology, 2011
- Embryotoxicity and fetotoxicity following intraperitoneal administrations of hexavalent chromium to pregnant ratsZygote, 2010
- Arsenic Inhibits Myogenic Differentiation and Muscle RegenerationEnvironmental Health Perspectives, 2010
- Reflections on hexavalent chromium: health hazards of an industrial heavyweight.Environmental Health Perspectives, 2000
- Chromium induced teratogenicity in female ratToxicology Letters, 1996